Immune to Cancer: The CRI Blog
-
#AACR16 Update: New Hope for Patients with Rare Skin Cancer, Head & Neck Cancer
Anti-PD-1 blockade and two other types of immunotherapy effective in treating multiple tumor types.
-
#AACR16 Update: The Cancer Research Institute’s Impact on Immunotherapy
Since our founding in 1953, the Cancer Research Institute has pioneered the field of cancer immunology, and… -
#AACR16 Update: How Immune Infiltration Predicts Survival in Cancer Patients
The Immunoscore is the strongest prognostic marker in colorectal cancer.
-
#AACR16 Update: Combination Therapies to Improve Anti-cancer Immune Responses
Complementary treatments can help overcome resistance to immunotherapy.
-
#AACR16 Update: Engaging the Immune System to Treat Pancreatic Cancer
Immunotherapy strategies to treat pancreatic cancer could also be effective in other difficult-to-treat cancers.
-
#AACR16 Update: Checkpoint Inhibition and Improving Anti-Tumor Immunity
Releasing the brakes on the immune system to overcome cancer
-
#AACR16 Update: Deciphering the Cancer Genome & Developing Tailored Treatments
To conquer cancer, scientists must first unmask its identity
-
Immunotherapy’s Bright Future
Tech entrepreneur Sean Parker bets big on immunotherapy.
-
The Vital Connection Between Cancer and the Immune System
The 45-page e-book features current information on the latest clinical developments in the rapidly advancing field of…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.